Kelsey Natsuhara, MD
Clinical Fellow
Medicine
School of Medicine

Education & Training

Show all (3) Hide

• Diversity, Equity, and Inclusion Champion Training University of California 10/2020
• MD Harvard Medical School 05/2018
• BA Human Developmental and Regenerative Biology Harvard College 05/2013

Publications (18)

Top publication keywords:
Precision MedicineNeoadjuvant TherapyAntineoplastic Combined Chemotherapy ProtocolsImmunoglobulin Light ChainsNeoplasm Recurrence, LocalPerineumMultiple MyelomaBreast NeoplasmsObstetric Labor ComplicationsNurse MidwivesAmyloidosisGenetic TestingLacerationsImmunoglobulin Light-chain AmyloidosisChemotherapy, Adjuvant

• 381P Treatment rechallenge after grade 1 trastuzumab-deruxtecan related interstitial lung disease: A real-world experience.
  Annals of Oncology 2024 K.H. Natsuhara, M. Vella, S.C. Behr, L. Quintal, J. Chien, M.E. Melisko, M. Majure, G.C. Buckle, A.H. Ko, H.S. Rugo
• Impact of Systemic Therapy on Fertility in Women with Early-Stage Breast Cancer.
  Current breast cancer reports 2024 Natsuhara KH, Chien AJ
• Significance of the pee-value: relevance of 24-hour urine studies for patients with myeloma.
  Leukemia & lymphoma 2023 Natsuhara KH, Huang CY, Knoche J, Arora S, Chung A, Martin T, Wolf J, Wong SW, Shah N, Banerjee R
• Daratumumab Plus Bortezomib and Dexamethasone in Newly Diagnosed Systemic Light Chain Amyloidosis.
  Current problems in cancer 2023 Kennedy VE, Natsuhara K, Maringanti SA, Shah ND, Arora S, Wolf J, Martin TG, Aras MA, Chung A, Wong SW
• Significance of the Pee-Value: Relevance of Urine Studies for Patients with Myeloma Undergoing Transplantation.
  Blood 2022 Kelsey H. Natsuhara, Chiung-Yu Huang, Jennifer Knoche, Shagun Arora, Alfred Chung, Thomas Martin, Jeffrey L. Wolf, Sandy W. Wong, Nina Shah, Rahul Banerjee

Show all (13 more) Hide

• Infectious complications in patients with relapsed refractory multiple myeloma after BCMA CAR T-cell therapy.
  Blood advances 2022 Kambhampati S, Sheng Y, Huang CY, Bylsma S, Lo M, Kennedy V, Natsuhara K, Martin T, Wolf J, Shah N, Wong SW
• The Distance Between Us: the COVID-19 Pandemic's Effects on Burnout Among Resident Physicians.
  Medical science educator 2021 Natsuhara KH, Borno HT
• Evaluating predictors of renal injury with sorafenib in hepatocellular carcinoma: A multi-ethnic cohort study.
  Journal of Onco-Nephrology 2021 Kelsey H Natsuhara, Li Zhang, Christopher A Carlos, Hala T Borno
• Infectious Complications of BCMA-Targeted and CD19-Targeted Chimeric Antigen Receptor T-Cell Immunotherapy.
  Blood 2020 Swetha Kambhampati, Bita Fakhri, Ying Sheng, Chiung-Yu Huang, Sophia Byslma, Kelsey Natsuhara, Dhruba Biswas, Mimi Lo, Weiyun Z. Ai, Lawrence D Kaplan, Thomas Martin, Jeffrey L. Wolf, Nina Shah, …
• Prognostic Significance of Residual Axillary Nodal Micrometastases and Isolated Tumor Cells After Neoadjuvant Chemotherapy for Breast Cancer.
  Annals of surgical oncology 2019 Wong SM, Almana N, Choi J, Hu J, Gagnon H, Natsuhara K, Shen AH, DeSantis S, Dominici L, Golshan M, Weiss A, Bellon J, Mittendorf EA, King TA
• Impact of Genomic Assay Testing and Clinical Factors on Chemotherapy Use After Implementation of Standardized Testing Criteria.
  The oncologist 2018 Natsuhara KH, Losk K, King TA, Lin NU, Camuso K, Golshan M, Pochebit S, Brock JE, Bunnell CA, Freedman RA
• Nurse-midwives' ability to diagnose acute third- and fourth-degree obstetric lacerations in western Kenya.
  BMC pregnancy and childbirth 2017 Pinder LF, Natsuhara KH, Burke TF, Lozo S, Oguttu M, Miller L, Nelson BD, Eckardt MJ
• Implementation of Surgeon-Initiated Gene Expression Profile Testing (Onco type DX) Among Patients With Early-Stage Breast Cancer to Reduce Delays in Chemotherapy Initiation.
  Journal of oncology practice 2017 Losk K, Freedman RA, Lin NU, Golshan M, Pochebit SM, Lester SC, Natsuhara K, Camuso K, King TA, Bunnell CA
• Distinct Roles for Matrix Metalloproteinases 2 and 9 in Embryonic Hematopoietic Stem Cell Emergence, Migration, and Niche Colonization.
  Stem cell reports 2017 Theodore LN, Hagedorn EJ, Cortes M, Natsuhara K, Liu SY, Perlin JR, Yang S, Daily ML, Zon LI, North TE
• Implementation of surgeon-initiated Oncotype DX ordering among patients with breast cancer to reduce chemotherapy wait times.
  Journal of Clinical Oncology 2017 Katya Losk, Rachel A. Freedman, Nancy U. Lin, Mehra Golshan, Susan Lester, Stephen Pochebit, Kelsey Natsuhara, Kristen Camuso, Tari A. King, Craig A. Bunnell
• Distinct roles for matrix metalloproteinases 2 and 9 in embryonic hematopoietic stem cell production.
  Experimental Hematology 2016 Lindsay Theodore, Mauricio Cortes, Kelsey Natsuhara, Sarah Liu, Virginie Esain, Trista E. North
• Transforming the clinical trial process: The I-SPY 2 trial as a model for improving the efficiency of clinical trials and accelerating the drug-screening process.
  Journal of Clinical Oncology 2014 Meredith B. Buxton, Kelsey Natsuhara, Angela DeMichele, Jane Perlmutter, Nola M Hylton, Douglas Yee, Laura van't Veer, William Fraser Symmans, Michael Hogarth, Julia Lyandres, Sarah E Davis, Susan …
• Vitamin D3 Modulates Definitive Hematopoiesis by Two Distinct Mechanisms in the Developing Zebrafish Embryo.
  Blood 2012 Mauricio Cortes, Kelsey Natsuhara, Wolfram Goessling, Trista E. North